companydata.dkcompanydata.dk

ILLUMINA DENMARK ApS: Financial statements 2025

CVR: 34087423

Source: annual report 2025, Danish Business Authority

01/01/2025 – 31/12/2025

ILLUMINA DENMARK ApS (CVR 34087423) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 32,340,749 and a net result of DKK 9,888,191 compared with DKK 10,130,208 the year before. That is a decrease of 16.4% compared with the year before. Equity in the 2025 report amounted to DKK 16,104,373. The solvency ratio was 17.2%. The company had 16 employees in the financial year.

Gross Profit
DKK 32,340,749
Profit/Loss
DKK 9,888,191
Equity
DKK 16,104,373
Total Assets
DKK 93,730,067
Employees
16

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025-32.3M9.9M16.1M16
2024-38.7M10.1M39.2M16
2023-26.2M8.6M29.1M12
2022-23.5M9M20.4M12
2021-22.8M8.1M11.4M11

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is ILLUMINA DENMARK ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2025

ILLUMINA DENMARK ApS wins public contractDec 19, 2025

ILLUMINA DENMARK ApS has won the tender "INDKØB AF PLATFORM TIL DNA SEKVENSERING" issued by Københavns Universitet worth 5,317,571 USD.

ILLUMINA DENMARK ApS wins public contractOct 1, 2025

ILLUMINA DENMARK ApS has won the tender "Supply of Consumables for Illumina Sequencing Machines" issued by Københavns Universitet worth 15,700,000 USD.

ILLUMINA DENMARK ApS wins public contractAug 8, 2025

ILLUMINA DENMARK ApS has won the tender "Indkøb af forbrugsartikler til Illumina udstyr" issued by Danmarks Tekniske Universitet - DTU worth 5,000,000 DKK.

Nicholas Simon Sales joins ILLUMINA DENMARK ApS as directorJul 21, 2025

As of July 21, 2025, Nicholas Simon Sales is registered as director of ILLUMINA DENMARK ApS.

ILLUMINA DENMARK ApS wins public contractJun 25, 2025

ILLUMINA DENMARK ApS has won the tender "Indkøb af NextSeq 550 til Patologi AUH" issued by Region Midtjylland worth 593,200 USD.

ILLUMINA DENMARK ApS: The 2024 annual report is outMay 15, 2025

ILLUMINA DENMARK ApS has published its annual report for 2024. Gross profit came to DKK 38,664,567, and the net result was DKK 10,130,208.

Louise Bach Jensen joins ILLUMINA DENMARK ApS as directorMar 25, 2025

As of March 25, 2025, Louise Bach Jensen is registered as director of ILLUMINA DENMARK ApS.

Nicola Letha Cranfield steps down as director of ILLUMINA DENMARK ApSMar 25, 2025

As of March 25, 2025, Nicola Letha Cranfield has stepped down as director of ILLUMINA DENMARK ApS.

ILLUMINA DENMARK ApS wins public contractMar 14, 2025

ILLUMINA DENMARK ApS has won the tender "Sekvenator" issued by Københavns Universitet worth 1,439,057 USD.

ILLUMINA DENMARK ApS wins public contractMar 7, 2025

ILLUMINA DENMARK ApS has won the tender "Indkøb af NovaSeq 6000 Reagent Kit" issued by Syddansk Universitet worth 3,137,723 DKK.

About ILLUMINA DENMARK ApS

ILLUMINA DENMARK ApS is a Danish company of the type Anpartsselskab based in København S, founded in 2011. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Louise Bach Jensen, Nicholas Simon Sales and Norbert Maria Hubert Keller. The company is owned by Illumina Netherland BV. The company has 15 employees (2026). In 2025, the company reported a gross profit of DKK 32,340,749 and a net result of DKK 9,888,191 compared with DKK 10,130,208 the year before. Equity in the 2025 report amounted to DKK 16,104,373.

Source: annual report 2025, Danish Business Authority